ANTIBODY-RESPONSES TO THE ENV EPITOPES OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN RHESUS MACAQUES NATURALLY INFECTED WITH SIMIAN T-LYMPHOTROPIC VIRUS TYPE-I

被引:3
|
作者
RUDOLPH, DL
YEE, J
PALKER, T
COLIGAN, JE
LAL, RB
机构
[1] UNIV CALIF DAVIS,CALIF PRIMATE RES CTR,SIMIAN RETROVIRUS REF LAB,DAVIS,CA 95616
[2] DUKE UNIV,MED CTR,DIV RHEUMATOL & IMMUNOL,DURHAM,NC 27710
[3] NIAID,BIOL RESOURCES BRANCH,BETHESDA,MD 20892
来源
RESEARCH IN VIROLOGY | 1993年 / 144卷 / 03期
关键词
HTLV; STLV; ENVELOPE PROTEIN; EPITOPE; IMMUNODOMINANCE; SYNTHETIC PEPTIDE; SENSITIVITY;
D O I
10.1016/S0923-2516(06)80029-4
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Synthetic peptides derived from the env protein of human T-lymphotropic virus type I (HTLV-I) were used to identify the immunodominant motifs in rhesus macaques naturally infected with simian T-lymphotropic virus type I (STLV-I). Of the 13 peptides derived from the env protein of HTLV-I, Env-1(191-214) and Env-5(242-257) reacted with 81 % (44/54) and 54 % (29/54) of specimens from infected monkeys, respectively. A recombinant protein (MTA-I162-209) reacted with 53 of 54 (98 %) STLV-1-infected serum specimens. While similar immune reactivities to Env-1 and MTA-1 were observed in both HTLV-I-infected human sera and STLV-I-infected monkey sera, the reactivity to Env-5 was significantly higher in HTLV-I-infected human sera. Differential reactivities may be attributed to the differences in the secondary structures of the STLV-I and HTLV-I envelope protein in the Env-5 region, since homologous peptide with STLV-I sequence did not result in enhanced sensitivity of anti-Env-5 antibody detection.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 50 条
  • [1] SEXUAL TRANSMISSION OF SIMIAN T-LYMPHOTROPIC VIRUS TYPE-I - A MODEL OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I INFECTION
    LAZO, A
    BAILER, RT
    LAIRMORE, MD
    YEE, JAL
    ANDREWS, J
    STEVENS, VC
    BLAKESLEE, JR
    LEUKEMIA, 1994, 8 : S222 - S226
  • [2] HUMAN T-LYMPHOTROPIC VIRUS TYPE-I UVEITIS
    YAMAGUCHI, K
    MOCHIZUKI, M
    WATANABE, T
    MIYATA, N
    TAJIMA, K
    MORI, S
    TAKATSUKI, K
    LEUKEMIA, 1994, 8 : S88 - S90
  • [3] HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN JAPAN
    YAMAGUCHI, K
    LANCET, 1994, 343 (8891): : 213 - 216
  • [4] MANIFESTATIONS OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I INFECTION
    KIM, JH
    DURACK, DT
    AMERICAN JOURNAL OF MEDICINE, 1988, 84 (05): : 919 - 928
  • [5] SEROLOGIC CONFIRMATION OF SIMIAN T-LYMPHOTROPIC VIRUS TYPE-I INFECTION BY USING IMMUNOASSAYS DEVELOPED FOR HUMAN T-LYMPHOTROPIC VIRUS-ANTIBODY DETECTION
    RUDOLPH, DL
    YEE, J
    MONE, J
    FOUNG, SKH
    LIPKA, JJ
    REYES, GR
    HADLOCK, K
    CHAN, L
    VILLINGER, F
    LAIRMORE, MD
    SINHA, S
    LAL, RB
    JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (04) : 858 - 861
  • [6] OCULAR MANIFESTATIONS IN PATIENTS INFECTED WITH HUMAN T-LYMPHOTROPIC VIRUS TYPE-I
    OHBA, N
    MATSUMOTO, M
    SAMESHIMA, M
    KABAYAMA, Y
    NAKAO, K
    UNOKI, K
    UEHARA, F
    KAWANO, K
    MARUYAMA, I
    OSAME, M
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 1989, 33 (01) : 1 - 12
  • [7] HUMAN AND SIMIAN GLIAL-CELLS INFECTED BY HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN CULTURE
    WATABE, K
    SAIDA, T
    KIM, SU
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1989, 48 (06): : 610 - 619
  • [8] HUMAN T-LYMPHOTROPIC VIRUS TYPE-I INFECTIONS IN WESTERN INDIA
    SINGHAL, BS
    LALKAKA, JA
    SONODA, S
    HASHIMOTO, K
    NOMOTO, M
    KUBOTA, R
    OSAME, M
    AIDS, 1993, 7 (01) : 138 - 139
  • [9] HUMAN T-LYMPHOTROPIC VIRUS TYPE-I TRANSCRIPTIONAL REPLICATION BY METHYLATION
    SAGGIORO, D
    PANOZZO, M
    CHIECOBIANCHI, L
    CANCER RESEARCH, 1990, 50 (16) : 4968 - 4973
  • [10] THE EPIDEMIOLOGY OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I AND TYPE-II
    KAPLAN, JE
    KHABBAZ, RF
    REVIEWS IN MEDICAL VIROLOGY, 1993, 3 (03) : 137 - 148